Talazoparib, sold under the brand name Talzenna, is an orally available poly ADP ribose polymerase inhibitor developed by Pfizer for the treatment of advanced breast cancer with germline BRCA mutations. Reference standards of Talazoparib API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
Talazoparib
Catalogue No.:PA 20 3890000
CAS :
Molecular Formula : C19H14F2N6O
Molecular Weight : 380.36
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....